Clinical Conversations: Molnupiravir in COVID-19
There have been over 526 million confirmed cases and over 6 million deaths worldwide since the coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2...
The Latest Guideline-Recommended Integrase Inhibitor for the Treatment of HIV Infection – Expert Opinions
Over the past decade, treatments for human immunodeficiency virus (HIV) infection have become more efficacious, safer and more satisfying from the patient’s perspective. Bictegravir (BIC) is the...
Beyond an undetectable HIV viral load: an update for nurses and pharmacists
Fiona Marple-Clark,a Alison Bell,b Hamish Bowden,c David Crawford,d Vickie Knight,e Samantha Libertino,f Don E Smithc,g...
Exploring the Difference between 2-Drug and 3-Drug Regimens in HIV Treatment
International guidelines for the management of human immunodeficiency virus (HIV) infection have been updated recently. In addition, there is emerging evidence on the use of dual therapies for the...
Beyond undetectable: considerations for nurses and pharmacists who care for people with HIV
Fiona Marple-Clark,a Bruce Hamish Bowden,b Jayne Howard,c Ngaire Latch,d John McAllister,e Maggie Smith,b Leah Williamsf...
Dolutegravir-Basierte Regime
Einleitung Die in den letzten zwanzig Jahren erzielten Fortschritte in der antiretroviralen Therapie (ART) ermöglichen HIV-infizierten Menschen heute eine weitgehend normale Lebenserwartung (1)....
Going beyond undetectable: a review of the unmet long-term health needs of people living with HIV
Overall prevalence of HIV in Europe Since surveillance of the HIV epidemic began, more than half a million (504,455) HIV diagnoses have been reported in EU/EEA countries (Austria, Belgium,...
HIV Therapie
Seit der Entdeckung des HIV-1 Virus 1983 und dem Beginn des Kampfes gegen das erworbene Immunschwächesyndrom hat die Entwicklung der antiretroviralen Medikation entscheidende Fortschritte gemacht....